Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 123, Issue 2, Pages 812-822Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI64093
Keywords
-
Categories
Funding
- Deutsche Forschungsgemeinschaft
Ask authors/readers for more resources
Klotho is a potent regulator of 1,25-hydroxyvitamin D3 [1,25(OH)(2)D-3] formation and calcium-phosphate metabolism. Klotho-hypomorphic mice (kl/kl mice) suffer from severe growth deficits, rapid aging, hyperphosphatemia, hyperaldosteronism, and extensive vascular and soft tissue calcification. Sequelae of klotho deficiency are similar to those of end-stage renal disease. We show here that the mineralocorticoid receptor antagonist spironolactone reduced vascular and soft tissue calcification and increased the life span of kl/kl mice, without significant effects on 1,25(OH)(2)D-3, FGF23, calcium, and phosphate plasma concentrations. Spironolactone also reduced the expression of osteoinductive Pit1 and Tnfa mRNA, osteogenic transcription factors, and alkaline phosphatase (Alpl) in calcified tissues of WO mice. In human aortic smooth muscle cells (HAoSMCs), aldosterone dose-dependently increased PM mRNA expression, an effect paralleled by increased expression of osteogenic transcription factors and enhanced ALP activity. The effects of aldosterone were reversed by both spironolactone treatment and PIT1 silencing and were mitigated by FGF23 cotreatment in HAoSMCs. In conclusion, aldosterone contributes to vascular and soft tissue calcification, an effect due, at least in part, to stimulation of spironolactone-sensitive, PIT1-dependent osteoinductive signaling.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available